EDNRB and cutaneous melanoma: The NCI60 Cancer Microarray project described a high expression level of the endothelin receptor type B (ENRB) in skin melanoma (Ross et al, 2000), and Demunter et al (2001) reported evidence for its role as a tumour progression marker in this tumour type.